• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴浆细胞淋巴瘤/华氏巨球蛋白血症中的核蛋白失调。

Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.

机构信息

Department of Pathology, Northwestern University-Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

Am J Clin Pathol. 2013 Feb;139(2):210-9. doi: 10.1309/AJCP0YGM8BLFYHJY.

DOI:10.1309/AJCP0YGM8BLFYHJY
PMID:23355206
Abstract

Waldenström macroglobulinemia (WM) is characterized by monoclonal gammopathy, usually IgM, in association with lymphoplasmacytic lymphoma (LPL). Little is known of the expression of nuclear proteins involved in B-cell development in LPL/WM. In this study, the expression patterns of PAX5/BSAP, MUM1/IRF4, and PRDM1/BLIMP1 were analyzed in plasma cells and lymphocytes in 29 cases of newly diagnosed LPL/WM by double immunohistochemical staining with CD138 and CD22. These patterns were compared with the expression profiles seen in normal bone marrow samples, reactive tonsils, and cases of plasma cell myeloma and marginal zone lymphoma. The median percentage of plasma cells coexpressing CD138 and PAX5 was significantly higher in LPL/WM compared with benign tissues (P = .001), marginal zone lymphoma (P = .002), and plasma cell myeloma (P < .0001), whereas the median percentage of plasma cells coexpressing CD138 and MUM1 was lower in LPL/WM than plasma cells in benign tissues (P = .02), marginal zone lymphoma (P = .001), and plasma cell myeloma (P = .0002). These findings show that a subset of plasma cells in LPL/WM demonstrates a nuclear protein expression pattern characteristic of the B-cell developmental program. Thus, the results better define the immunophenotypic profile of the neoplastic cells in LPL/WM.

摘要

华氏巨球蛋白血症(WM)的特征是单克隆丙种球蛋白病,通常为 IgM,与淋巴浆细胞淋巴瘤(LPL)相关。在 LPL/WM 中,与 B 细胞发育相关的核蛋白的表达情况知之甚少。在这项研究中,通过双重免疫组织化学染色用 CD138 和 CD22 分析了 29 例新诊断的 LPL/WM 中浆细胞和淋巴细胞中的 PAX5/BSAP、MUM1/IRF4 和 PRDM1/BLIMP1 的表达模式。将这些模式与正常骨髓样本、反应性扁桃体和浆细胞骨髓瘤和边缘区淋巴瘤的表达谱进行了比较。与良性组织(P =.001)、边缘区淋巴瘤(P =.002)和浆细胞骨髓瘤(P <.0001)相比,LPL/WM 中共同表达 CD138 和 PAX5 的浆细胞的中位数百分比明显更高,而 LPL/WM 中共同表达 CD138 和 MUM1 的浆细胞的中位数百分比则低于良性组织(P =.02)、边缘区淋巴瘤(P =.001)和浆细胞骨髓瘤(P =.0002)中的浆细胞。这些发现表明,LPL/WM 中的一部分浆细胞表现出与 B 细胞发育程序特征一致的核蛋白表达模式。因此,结果更好地定义了 LPL/WM 中肿瘤细胞的免疫表型特征。

相似文献

1
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.淋巴浆细胞淋巴瘤/华氏巨球蛋白血症中的核蛋白失调。
Am J Clin Pathol. 2013 Feb;139(2):210-9. doi: 10.1309/AJCP0YGM8BLFYHJY.
2
[Clinicopathologic features of lymphoplasmacytic lymphoma].[淋巴浆细胞性淋巴瘤的临床病理特征]
Zhonghua Bing Li Xue Za Zhi. 2010 May;39(5):308-12.
3
[Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].[伴有华氏巨球蛋白血症的淋巴浆细胞淋巴瘤:40例中国患者的临床病理及免疫表型研究]
Zhonghua Bing Li Xue Za Zhi. 2009 Nov;38(11):728-32.
4
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.核BCL-10表达在淋巴浆细胞淋巴瘤/华氏巨球蛋白血症中很常见,且与p65核因子-κB激活无关。
Mod Pathol. 2006 Jul;19(7):891-8. doi: 10.1038/modpathol.3800609. Epub 2006 Apr 21.
5
Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.累及髓外部位的华氏巨球蛋白血症:44例患者的形态学和免疫表型研究结果
Am J Surg Pathol. 2003 Aug;27(8):1104-13. doi: 10.1097/00000478-200308000-00007.
6
Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS.骨髓芯活检模式在淋巴浆细胞淋巴瘤/华氏巨球蛋白血症中的诊断价值及靶向 NGS 检测其突变特征。
J Clin Pathol. 2020 Sep;73(9):571-577. doi: 10.1136/jclinpath-2019-206282. Epub 2020 Jan 24.
7
Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.淋巴浆细胞淋巴瘤和华氏巨球蛋白血症。
Arch Pathol Lab Med. 2013 Apr;137(4):580-5. doi: 10.5858/arpa.2012-0034-RS.
8
Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.眼附属器结外边缘区B细胞淋巴瘤中的浆细胞分化:136例肿瘤性浆细胞表型分析及其预后意义
Br J Ophthalmol. 2005 Mar;89(3):352-9. doi: 10.1136/bjo.2004.047092.
9
Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.华氏巨球蛋白血症中B淋巴细胞和浆细胞的基因表达谱分析:与慢性淋巴细胞白血病、多发性骨髓瘤及正常个体相同细胞对应物的表达模式比较
Leukemia. 2007 Mar;21(3):541-9. doi: 10.1038/sj.leu.2404520. Epub 2007 Jan 25.
10
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.CD13 在 B 细胞恶性肿瘤中的表达是浆细胞分化的标志。
Br J Haematol. 2019 Feb;184(4):625-633. doi: 10.1111/bjh.15584. Epub 2018 Sep 10.

引用本文的文献

1
Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.单细胞图谱揭示了瓦尔登斯特伦巨球蛋白血症中的肿瘤细胞异质性和免疫抑制微环境。
J Transl Med. 2022 Dec 9;20(1):576. doi: 10.1186/s12967-022-03798-6.
2
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.在复发或难治性华氏巨球蛋白血症中联合使用伊沙佐米、皮下利妥昔单抗和地塞米松:HOVON124/ECWM-R2 研究的 I 期/II 期最终分析。
J Clin Oncol. 2022 Jan 1;40(1):40-51. doi: 10.1200/JCO.21.00105. Epub 2021 Aug 13.
3
The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma.
BLIMP1-EZH2 轴在非霍奇金淋巴瘤中的作用。
Oncogene. 2020 Jul;39(28):5138-5151. doi: 10.1038/s41388-020-1347-8. Epub 2020 Jun 12.
4
PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma.边缘区淋巴瘤和淋巴浆细胞性淋巴瘤中PRDM1的表达水平。
Int J Clin Exp Pathol. 2017 Aug 1;10(8):8610-8618. eCollection 2017.
5
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.6p25.3 和 14q32.13 上的两个瓦尔登斯特伦巨球蛋白血症的高风险易感基因座。
Nat Commun. 2018 Oct 10;9(1):4182. doi: 10.1038/s41467-018-06541-2.
6
Transgenic mouse model of IgM lymphoproliferative disease mimicking Waldenström macroglobulinemia.模仿华氏巨球蛋白血症的IgM淋巴细胞增殖性疾病转基因小鼠模型。
Blood Cancer J. 2016 Nov 4;6(11):e488. doi: 10.1038/bcj.2016.95.
7
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.具有浆细胞分化的小B细胞淋巴瘤的多种面貌及MYD88检测的作用
Virchows Arch. 2016 Mar;468(3):259-75. doi: 10.1007/s00428-015-1858-9. Epub 2015 Oct 10.
8
Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.华氏巨球蛋白血症:临床与免疫学方面、自然病史、起源细胞及新兴小鼠模型
ISRN Hematol. 2013 Sep 9;2013:815325. doi: 10.1155/2013/815325.